Voyager Therapeutics Inc (MEX:VYGR)
MXN 165 0 (0%) Market Cap: 6.53 Bil Enterprise Value: 325.05 Mil PE Ratio: 8.89 PB Ratio: 0.95 GF Score: 75/100

Q2 2024 Voyager Therapeutics Inc Earnings Call Transcript

Aug 06, 2024 / 08:30PM GMT
Release Date Price: MXN165
Operator

Good afternoon, and welcome to the Voyager Therapeutics second-quarter 2024 financial results conference call. (Operator Instructions) Please note that today's call is being recorded. Replay of today's call will be available on the Investors section of the company website approximately two hours after completion of this call.

I would now like to turn the call over to Trista Morrison, Chief Corporate Affairs Officer at Voyager.

Trista Morrison
Voyager Therapeutics Inc - Chief Corporate Affairs Officer and Chief of Staff to the CEO

Thank you, and good afternoon. We issued our second-quarter 2024 financial results press release this afternoon. The press release and 10-Q are available on our website.

Joining me on today's call are Dr. Al Sandrock, our Chief Executive Officer; Dr. Toby Ferguson, our Chief Medical Officer; and Dr. Nathan Jorgensen, our Chief Financial Officer. We will also be joined for the Q&A portion of the call by Dr. Todd Carter, our Chief Scientific Officer.

Before we get started, I'd like to remind everyone

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot